You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Investigational Drug Information for Lysergic acid diethylamide


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Lysergic acid diethylamide?

Lysergic acid diethylamide is an investigational drug.

There have been 20 clinical trials for Lysergic acid diethylamide. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2023.

The most common disease conditions in clinical trials are Headache, Cluster Headache, and Anxiety Disorders. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Eleusis Therapeutics, and University of Fribourg.

There are four hundred and fifty-one US patents protecting this investigational drug and zero international patents.

Recent Clinical Trials for Lysergic acid diethylamide
TitleSponsorPhase
LSD Occupancy of the Serotonin 2A Receptor in the Human BrainRigshospitalet, DenmarkEarly Phase 1
Lysergic Acid Diethylamide (LSD) in Palliative CareUniversity Hospital, ZürichPhase 2
Lysergic Acid Diethylamide (LSD) in Palliative CareUniversity Hospital, Basel, SwitzerlandPhase 2

See all Lysergic acid diethylamide clinical trials

Clinical Trial Summary for Lysergic acid diethylamide

Top disease conditions for Lysergic acid diethylamide
Top clinical trial sponsors for Lysergic acid diethylamide

See all Lysergic acid diethylamide clinical trials

US Patents for Lysergic acid diethylamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lysergic acid diethylamide ⤷  Sign Up Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA) ⤷  Sign Up
Lysergic acid diethylamide ⤷  Sign Up Personal substance detection field test kit Lindon Group, Inc. (East Providence, RI) ⤷  Sign Up
Lysergic acid diethylamide ⤷  Sign Up Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lysergic acid diethylamide

Drugname Country Document Number Estimated Expiration Related US Patent
Lysergic acid diethylamide Australia AU2003247876 2022-07-05 ⤷  Sign Up
Lysergic acid diethylamide Canada CA2491572 2022-07-05 ⤷  Sign Up
Lysergic acid diethylamide Canada CA2569958 2022-07-05 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.